Retinal Age Model Tied to Disease Risk

• by Andrea Surnit

• May 1, 2026

FDA Monthly Preview: Key May Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• April 29, 2026

• 4 min

FDA approves first at-home therapy for thyroid eye disease

The first at-home subcutaneous treatment for thyroid eye disease met its primary end point in 1 of 2 phase 3 trials.

• by Mouj Hijazi

• October 16, 2026

• 2 min

Interoperable Integration of a National Rare Disease Registry Into a Rare Eye Disease Data Warehouse: Implementation Study

• by Camille Beluffi Marin, Marilyne Oswald, Laura Ratenet, Matthieu Stoll, Kirsley Chennen, Hélène Dollfus

• May 26, 2026